CAV1 and glioblastoma: reported that bioactive miR-1238 could be incorporated into TMZ-resistant GBM cells-derived exosomes and absorbed by TMZ-sensitive cells, which disseminated TMZ resistance by directly targeting and suppressing caveolin-1 (CAV1) and subsequently activating EGFR-PI3K-Akt-mTOR pathway.